LEADER 01471nam  2200373   450 
001 9910707431503321
005 20160826161754.0
035   $a(CKB)5470000002465215
035   $a(OCoLC)957370543
035   $a(EXLCZ)995470000002465215
100   $a20160826d2014      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aParkinson's disease $ehope through research /$fprepared by Office of Communications and Public Liaison, National Institute of Neurological Disorders and Stroke, National Institutes of Health
210  1$aBethesda, Maryland :$cNational Institute of Neurological Disorders and Stroke, National Institutes of Health,$d2014.
215   $a1 online resource (50 pages) $ccolor illustrations
225 1 $aNIH publication ;$vno. 15-139
300   $aTitle from title screen (viewed Aug. 25, 2016).
300   $a"December 2014."
320   $aIncludes bibliographical references.
517   $aParkinson's disease 
606   $aParkinson's disease$zUnited States
615  0$aParkinson's disease
712 02$aNational Institute of Neurological Disorders and Stroke (U.S.),
712 02$aNational Institute of Neurological Disorders and Stroke (U.S.).$bOffice of Communications and Public Liaison,
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910707431503321
996   $aParkinson's disease$9281024
997   $aUNINA